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A challenge facing immunization registries is developing measures of childhood immunization coverage that contain more
information for setting policy than present vaccine series up-to-date (UTD) rates. This study combined milestone analysis with
provider encounter data to determine when children either do not receive indicated immunizations during medical encounters or
fail to visit providers. Milestone analysis measures immunization status at key times between birth and age 2, when recommended
immunizations ﬁrst become late. The immunization status of a large population of children in the Oregon ALERT immunization
registry and in the Oregon Health Plan was tracked across milestone ages. Findings indicate that the majority of children went
back and forth with regard to having complete age-appropriate immunizations over time. We also found that immunization UTD
rates when used alone are biased towards relating non-UTD status to a lack of visits to providers, instead of to provider visits on
which recommended immunizations are not given.
1.Introduction
A challenge to increasing early childhood immunizations on
astateorlocallevelisthelimitedabilityofstandardsummary
measures of up-to-date (UTD) rates to identify barriers
to improvement. Typically, early childhood UTD rates are
based on the number of doses of recommended vaccines,
by individual antigen or in total, that a cohort of children
receive by either a ﬁxed age or a ﬁxed date of assessment [1].
For the National Immunization Survey (NIS), this represents
the proportion of 19- to 35-month-old children having all
recommended doses for up to 7 vaccine types. Similarly,
health plans utilize a Healthcare Eﬀectiveness Data and
Information Set (HEDIS) immunization measure, which
counts the number of doses received by 24 months of age
[2,3].However,alowUTDrateamongapopulation,derived
using these measures, does not aid in determining why
the rate is low [4]. The growing complexity of the early
childhood immunization schedule, with up to 19 vaccine
doses recommended across at least 6 visits by age 2, means
that there are many points of time and many reasons
by which children can fall behind on immunizations [5].
While immunization summary UTD rates for 2-year-olds
can identify general problems, there is also a need for more
detailed assessment tools to describe local immunization
coverage and more speciﬁc vaccine usage [6].
One alternative method of evaluation is to consider age-
appropriate vaccinations. A substantial body of prior work
exists comparing summary UTD measures against more
speciﬁc assessments either for complete antigen series or
combinations when actually due without considering late
catch-up [7–9], or in comparison of individual antigens and
shots to when they are expected or late [10]. To the extent
thatearlychildhoodimmunizationsareoftenusedasaproxy
for the quality of early childhood routine care, the timeliness
of immunizations is a relevant measure—delayed or lagging
immunizations may reﬂect other issues with early childhood
care.2 Journal of Biomedicine and Biotechnology
One perspective on age-appropriate immunizations is to
track children’s progress through immunization milestones
between birth and age 2 [11]. Immunization milestones
are the ages at which recommended immunizations ﬁrst
become late according to the schedule developed by the
Advisory Committee on Immunization Practices (ACIP).
These milestones occur at 3, 5, 7, 16, 19, and 24 months of
age. When immunizations are tracked using this approach,
children’s progression through milestones unfolds as a story
of falling behind and catching up with recommended doses.
This is a beneﬁcial method as it facilitates identifying
provider failure to give all or some of the immunizations
that are due at healthcare encounters (missed opportu-
nities) or parental failure to bring children to providers
for vaccination-eligible encounters (missed visits). The
prevalence of missed opportunities and missed visits at
each milestone age can guide immunization interventions.
However, basing milestone analysis exclusively on immu-
nization record data may misclassify missed opportuni-
ties as missed visits, and shift the apparent burden of
children who are not appropriately immunized for their
age from providers to parents. This can occur because
healthcare encounters during which no vaccinations are
administered will not be captured into immunization record
datasets.
This study provides an example of using a milestone
approach to assess a speciﬁc population and their progres-
sion through early childhood immunizations, where both
payor-administrative and state-level immunization informa-
tion system (IIS) data are available. Combining children’s
healthcare encounter information from payer records with
theirimmunizationrecordsgivesamoreaccurateassessment
at each milestone age of the eﬀect of missed opportunities
and missed visits on age-appropriate immunizations and
overall immunization rates.
2. Methods
2.1. Data Sources. The study population consisted of a
birth cohort of Oregon children enrolled in the Oregon
Health Plan (OHP) and whose immunization records were
in the Oregon ALERT Immunization Information System
(ALERT IIS). ALERT IIS immunization records were merged
with provider encounter records from the OHP for this
population. The ALERT IIS is a statewide immunization
registry which receives immunization records from 97%
of Oregon private healthcare providers and 100% of the
immunization records from public providers. The OHP is
Oregon’s public healthcare plan that provides healthcare
coverage for children in families living below 185% of the
federal poverty level and covers both those with traditional
Medicaid eligibility as well as an expanded State Children’s
Health Insurance Program (SCHIP) population. The major-
ity of OHP-enrolled children are placed in commercially
available managed care plans. Immunization records for
OHP children are available both from OHP collected records
for billing and encounters as well as from direct provider
record submissions to ALERT.
2.2. Data Setup. For this study, ALERT IIS records and OHP
encounter records were selected from their respective data
systemsforchildrenbornin2005.Immunizationrecordsand
encounter data were restricted to those received through the
child’s 24th month of age. Children’s records were merged
across the two data systems based on the child’s name, date
of birth, and county of residence. The matching process
was based on the observation that within the 2005 Oregon
birth cohort, a combination of name and date of birth was
over 99.9% unique, with almost all exceptions resolving with
the inclusion of residence. This high-probability matching
process was selected over the usual process ALERT uses to
incorporate OHP and other administrative data, wherein a
hard-match is required also on additional information such
as address or phone number.
Immunization records were selected for the six vaccines
(including combination vaccines) included in the recom-
mended “4:3:1:3:3:1” series. The 4:3:1:3:3:1 series consists of
4 diphtheria, tetanus toxoid, and acellular pertussis (DTaP);
3 poliovirus (IPV); 1 measles, mumps, and rubella (MMR),
3 Haemophilus inﬂuenzae type b (Hib); 3 hepatitis B (HepB),
and 1 varicella. (VAR) vaccines. Records for these vaccines
were reviewed for appropriate age and interval between
doses, according to the 2007 ACIP Immunization Schedule.
Doses given too early or with insuﬃcient spacing between
doses to be considered valid were removed from the analysis.
To ensure that records of encounters would be available
to compare with immunizations at all of the milestone ages,
children with limited enrollment or nonenrollment at key
ages were excluded from the ﬁnal analysis dataset. The study
populationwasrestrictedtochildrenenrolledinOHPwithin
30 days of birth, with a cumulative total of at least 365 days
ofenrollmentbyage2,andcontinuousenrollmentacrossthe
key period of 15 to 18 months, when the 4th dose of DTaP is
due. Because OHP enrollment generally occurs in 12-month
blocks, the majority of children meeting the above require-
ments were also continuously enrolled through their second
birthday. Children born outside Oregon were excluded since
possibly both early encounters and immunizations would
notbereportedtoALERTorOHP.Childrenwithonlyabirth
dose of hepatitis B and no other vaccines in ALERT also were
excluded.
The OHP requires health plans and providers to submit
detailed encounter records on enrolled children for all
services received. For OHP-enrolled children, a subset of
vaccination-eligible encounters was created from all encoun-
ters, based on a review of ICD-9 and CPT coding in
OHP encounter records. A vaccination-eligible encounter
was deﬁned as an encounter occurring in a nonemergent
or noninpatient setting with a medical provider, and with
either a CPT procedure code indicating that routine care
or evaluation was performed, or an ICD-9 diagnostic code
indicating that the purpose of the encounter was consistent
with routine care and immunization evaluation. These
criteria were used to identify not only visits that providers
would deﬁne as well-child visits, but also other visits during
which immunizations could have been given, and include
nonemergent “sick” visits. In a few cases, ALERT had a
record of an immunization visit for which there was noJournal of Biomedicine and Biotechnology 3
matching OHP encounter record. This was usually found to
reﬂect free vaccinations without administration fees at sites
outside of those normally reporting to OHP, such as school
clinics, and some public health departments. These visits
were also counted as vaccination-eligible encounters. Also if
CPT codes for vaccine administration were found in OHP
data without other evidence of a shot-eligible encounter,
these were taken as indicating that a vaccine encounter
occurred.
2.3. Analysis. The deﬁnitions of milestone periods were
taken from Luman and Chu [11], and reﬂect the dates at
which recommended immunizations are ﬁrst late accord-
ing to the 2007 ACIP schedule. The milestone periods
occur at the start of 3 months, 5 months, 7 months, 16
months, 19 months, and 24 months of age. Immunization
(UTD) status at each milestone was evaluated for the
timely receipt of all doses due in the 4:3:1:3:3:1 series by
age 2. Additionally children were categorized according to
whether they had vaccination-eligible encounters in the
period prior to each milestone. In cases in which a non-
UTD child at a milestone had multiple encounters in the
prior period, and received vaccinations at some encounters
and not at others, they were counted as having a vaccina-
tion visit. Schematically, this classiﬁcation is presented in
Table 1.
At each milestone age, immunization status was com-
pared with the immunization status at the previous mile-
stone age to determine whether children had remained UTD,
remained non-UTD, fallen behind due to a missed visit,
fallen behind due to a missed opportunity, or caught up
with the immunization schedule. Children remained UTD
if they were UTD at the prior milestone age and UTD at the
current milestone age. Children remained non-UTD if they
were non-UTD at the prior milestone age and non-UTD at
the current milestone age. This classiﬁcation is presented in
Table 2.
Children fell behind due to a missed visit if they were
UTD at the prior milestone age, non-UTD at the current
milestone age, and had no record of a valid healthcare
visit or immunization record during the period in between.
Children fell behind due to a missed opportunity if they were
UTD at the prior milestone age, non-UTD at the current
milestone age, and had a vaccination-eligible healthcare
visit during the period in between. Children caught up if
they were non-UTD at the prior milestone age and UTD
at the current milestone age. An exception to the missed
opportunity calculation is for the 16-month milestone,
which includes the ﬁrst MMR vaccine. The MMR is not
valid before 12 months of age, so encounters between 7
months and 12 months were not counted as potential missed
opportunities.
As a check on the completeness of immunization visits
represented by this merged dataset, a Lincoln-Peterson
capture-recapture method was used to estimate the per-
centage of immunization visits for the study population
not captured by the ALERT IIS either by provider records
or by OHP administrative records. The total number of
immunization visits, both captured and uncaptured, was
estimated by
N =
[(A+1 ) ×(B +1 )]
(AB −1)
,( 1 )
where N is the total estimated number of visits, A is the
number of visits captured by provider reports in ALERT,
B is the number of visits captured by OHP billing and
administrative reports, and AB is the number of visits
captured in both by date.
The principal assessment tool of this study is a time-
based progression of young children across milestones and
age-appropriate immunizations, presented in a novel form
for easier depiction of change between milestones. The
data by milestone are presented for whether children were
complete on age-appropriate immunizations along with
categories for catching up and falling behind by milestone,
and by missed opportunities versus missed visits for non-
UTD children. Finally, a comparison of age-appropriate
milestoneresultsismadetoasummaryUTDmeasureforthe
4:3:1:3:3:1 immunization series assessed at 24 to 35 months
of age.
3. Results
Of 20,411 children born in 2005 who were enrolled in the
Oregon Health Plan for some period of time, 13,199 met
the requirements to be counted among the study population.
The reasons and scope of exclusions are presented in Table 3.
The numbers of those excluded are listed in the order they
were excluded and do not reﬂect the total prevalence of
each criterion in the population; for example, of the 1,004
childrenexcluded forbeing born outofOregon, themajority
would also have been excluded for length of enrollment. The
primary reason for exclusions from the study population
is nonenrollment after 1 year of age, so that no encounter
data would be reported to OHP. Also 2% of the study
population met all enrollment criteria except that they did
not have any reported immunizations. These may represent
true nonimmunized children, and were also excluded.
The count of total immunization visits across both
datasets was 74,919. The capture-recapture estimate of total
immunization visits for the study population was 76,087.
Thus the dataset appears relatively complete for all immu-
nization visits of the study population, with the combination
of ALERT IIS provider reports and OHP administrative data
capturing98.4%ofestimatedimmunizationvisitsamongthe
study population.
As shown in Figure 1, only 32% of children had all ACIP
recommended immunizations on time at all milestones,
while 14% were not complete at only one milestone,
15% were not complete at 2 milestones, and 9% were
not complete at any milestone. Also 41% of children had
vaccination-eligible encounters in all of the periods before
eachmilestone,and35%ofchildrenweremissingencounters
in only one of the periods before milestones. Another 14%
were missing encounters in 2 periods, and 10% were missing
encounters in 3 or more periods.4 Journal of Biomedicine and Biotechnology
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For milestone status based on having ACIP recommended immunizations
in the DTaP, HepB, Hib, MMR, polio, and varicella series by 3, 5, 7, 16, 19 & 24 months.
Source: Oregon ALERT IIS
Figure 1: Children by Count of Milestones with All Age-Appropriate Immunizations.
Table 1: Immunization Encounter Classiﬁcation.
Had immunizations by milestone?
Had provider encounters? Yes, UTD Yes, Non-UTD No
Yes Immunization Visit Missed Opportunity Missed Opportunity
No — — Missed Visit
Where UTD is up to date status for ACIP recommended immunizations in the DTaP, HepB, Hib, Polio, and Varicella series by each milestone age.
Table 2: Immunization Status Categorization.
At prior milestone
At current milestone UTD Non-UTD
Up to date (UTD) Remain UTD Catch Up
Non-UTD Fall Behind Stay Non-UTD
UTD is up to date status for ACIP recommended immunizations in the
DTaP, HepB, Hib, Polio, and Varicella series.
Rates of completeness of age-appropriate immunizations
per the ACIP schedule varied among the milestone ages,
from a high of 82.4% at 3 months of age to a low of 52.5%
at 19 months of age. For the ﬁnal milestone at 24-months,
no further vaccinations were due, and the ﬁnal 24 month
completion rate for the study population was 68.6%, with
16.1% catching up from the prior 19-month milestone. The
pattern of completion, falling behind, and catching up by
milestone period is presented in Figure 2.
While 17.6% of the study population had fallen behind
by the 3-month milestone, representing a late start on
immunizations, the most salient episode of falling behind
occurred at the 5-month milestone, where 21.0% of children
fell behind. In this analysis, children fell behind at all
Table 3: Population Size and Exclusions.
OHP children in ALERT: 20,411
Exclusions (in order applied)
N o tb o r ni nO r e g o n 1 , 0 0 4
<180 days of enrollment by age 2 1,123
<365 days of enrollment by age 2 583
Not enrolled within 30 days of birth 345
Not enrolled after 1 year of age 2,884
Not enrolled through 15–18-month period 1,009
No immunizations reported post birth 264
Total exclusions 7,212
Total study population 13,199
OHP is the Oregon Health Plan ALERT is the ALERT Immunization
Information System.
milestoneagesatwhichnewimmunizationswereadded.The
19-month milestone adds 4 antigens beyond the 16-month
milestone, including the fourth DTaP and varicella; and the
risk of falling behind between these milestones is calculated
from Table 2 as (16.7/61.3) = 27.2%. This is interpreted
as, for those who are on schedule at 16 months, 27.2%
will fall behind by 19 months. The largest total percentageJournal of Biomedicine and Biotechnology 5
61.4%
51.3% 46.5% 44.6%
52.5%
31.4%
3m o 5m o 7m o 1 6m o 1 9m o 2 4m o
Complete
(82.4%)
Complete
(62.6%) Complete
(58.1%)
Complete
(61.3%)
Complete
(52.5%)
Complete
(68.6%)
Not complete
(17.6%)
Not complete
(37.4%) Not complete
(41.9%)
Not complete
(38.7%)
Not complete
(47.5%)
Not complete
(31.4%)
Missed visit 5.5% Missed visit
7.2%
Missed visit 5.6% Missed visit 2.9% Missed visit
7.2% Missed visit
14% Missed opps
12.1%
Missed opps
13.2%
Missed opps
24.3%
Missed opps
19.3%
Missed opps
18.2%
Missed opps
17.4% Missed visit 3.2%
Missed visit
6.3% Missed visit 7.7%
Missed visit
12.6%
Missed opps
13.8%
Missed opps 5.7% Missed opps
8.8% Missed opps
9.5%
Shots due:
1H e p B ,1D T a P ,
1H i b ,1P o l i o
Shots due:
1H e p B ,2D T a P ,
2H i b ,2P o l i o
Shots due:
2H e p B ,3D T a P ,
3-4 Hib, 2 Polio
Shots due:
2H e p B ,3D T a P ,
3-4 Hib, 2 Polio,
1 MMR
Shots due:
3H e p B ,4D T a P ,
3-4 Hib, 3 Polio,
1 MMR, 1 Var
Shots due:
3H e p B ,4D T a P ,
3-4 Hib, 3 Polio,
1 MMR, 1 Var
Completeness is based on ACIP recommendations by age for diphtheria, tetanus toxoid, and pertussis (DTaP); poliovirus (IPV);
measles, mumps, and rubella (MMR), Haemophilus inﬂuenzae type b (Hib); hepatitis B (HepB), and varicella (VAR) vaccines.
Source: Oregon ALERT IIS
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Figure 2: Immunization Completeness At Milestone Ages (for Two Year Olds in 2007, N = 13,199).
of children without age-appropriate immunizations, 47.5%,
also occurred at the 19-month milestone. Overall, the
percentages of children who were not complete by milestone
from Table 2 with missed opportunities was 68.5% at 3
months, 72.2% at 5 months, 71.7% at 7 months, 72.5% at
16 months, 58.4% at 19 months, and 60.0% at 24 months.
Another approach to interpreting the reasons for chil-
dren falling behind is to further examine missed visits,
missed opportunities, and vaccination visits at each mile-
stone for those who were not complete. Figure 3 describes
how children who are not complete for age-appropriate
immunizations at any milestone have either missed visits
or missed opportunities, where missed opportunities are
divided between provider encounters with no shots received
versus encounters where some shots are received.
The percentage of noncomplete children per milestone
with provider encounters on which some shots were received
(vaccination visits) ranged from a high of 50.8% prior to
the 3-month milestone to a low of 15.2% before the 24-
month milestone. The percentage of children with provider
encounters and no shots, and without vaccination visits,
in each period is a measure of the amount by which
immunization-record-only data would misclassify missed
opportunities as missed visits. This potential misclassiﬁed
percentage of noncomplete children having vaccination-
eligible encounters with no reported vaccinations ranged
from a high of 44.8% at the 24-month milestone, to a low of
21.4% at the 5-month milestone. At the 3-month milestone,
noncomplete children were evenly divided between those
with no encounters on record during the period (31.4%),
those with encounters but no vaccinations (34.1%), and
those with encounters during which some vaccinations were
given (34.5%).
As a ﬁnal analysis, the results by milestone for encounters
and completeness were stratiﬁed by children’s status on a
summary UTD measure for having all shots in a 4:3:1:3:3:16 Journal of Biomedicine and Biotechnology
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Figure 3: Provider Encounters by Milestones for Children Lacking Complete Age-Appropriate Immunizations.
series by age 24 to 35 months, and using a ﬁxed date of
assessment.Overall77.8%ofthestudypopulationwereUTD
by 24 to 35 months for the 4:3:1:3:3:1 series. The comparison
across milestones for children who were UTD is presented in
Figure 4.
Of the children who were UTD by the date of assessment,
only 68% were complete for age-appropriate immunizations
by the 19-month milestone, 72% were complete by the
16-month milestone, 67% were complete at the 7-month
milestone,and71%werecompleteatthe5-monthmilestone.
The majority of those who were not complete at any
milestone, with the exception of the 24-month milestone,
also had encounters with providers on which some shots
were given.
Figure 5 presents the same analysis across milestones for
the22.2%ofthestudypopulation whowerenotUTDforthe
4:3:1:3:3:1 series at 24 to 35 months.
Children not UTD at 24–35 months were also not
complete for age-appropriate immunizations at 19 and 24
months by deﬁnition of which shots were required at these
milestones. Overall in Figure 5 the majority of non-UTD
children at 24 to 35 months who also were not complete
at milestones had substantial volumes of encounters with
providers. An analysis using only shot-record data, however,
would reach, falsely, the conclusion that the majority of
non-UTD children were missing provider encounters at each
milestone.
4. Discussion
The reality of children’s immunizations in the present study
population is a story of falling behind and catching up with
recommended immunizations. This ﬁnding is consistent
with prior application of a milestone age approach [11].
What this study adds to the understanding of milestones
and immunizations is a more accurate representation of how
missedopportunitiesandmissedvisitscontributetochildren
notbeingup-to-dateforrecommendedvaccines.Thepresent
ﬁnding that for many children, periods of missed visits in
immunization record data are actually periods of missed
opportunities is a ﬁrst in the analysis of larger, population-
based data systems such as immunization registries. This
ﬁnding should lead at least to caution in assigning reasons
regardingwhychildrenarenotup-to-dateaccordingtoeither
state-level immunization registries or other immunization
record data, including the National Immunization Survey.
The importance of this is that the prevalence of either
true missed visits or true missed opportunities should lead
to diﬀerent interventions to improve immunization rates.
Focusing on methods to improve rates of missed visits,
such as reminder-recalls to parents of children who appear
to have missing vaccinations and visits, may be of limited
utility if the greater issue is that the parents have brought
their children in to providers across milestones without
receiving needed vaccinations. As a recommendation toJournal of Biomedicine and Biotechnology 7
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Figure 4: Milestone Completeness and Provider Encounters for Children UTD for 4:3:1:3:3:1 Series by 24 to 35 Months.
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Figure 5: Milestone Completeness and Provider Encounters for Children Non-UTD for 4:3:1:3:3:1 Series by 24 to 35 Months.8 Journal of Biomedicine and Biotechnology
correct this problem, immunization record data for at least
a sample of covered children should be compared with
encounter records from billing and administrative sources
before considering appropriate immunization interventions.
Also, data collected from samples of provider records for
immunization assessment should include basic information
on all encounters, whether vaccinations were given or not.
In this study, the majority of children who were not
catching up at each milestone were having encounters with
providers. These encounters were potentially ones in which
missing vaccinations could be administered; however, con-
verting these missed opportunities to vaccination visits may
be diﬃcult. Provider reluctance to administer vaccinations
during sick or other nonroutine visits is a known barrier
to improving immunization rates, and may be diﬃcult to
change [12–14]. The type of encounter may also be a barrier
to receiving vaccinations in many clinics and healthcare
providers; for example, in urgent care encounters, when
limited time and a press of higher priority needs make
it diﬃcult to include review of records and delivery of
vaccinations [15–17]. While parental reluctance in such
circumstances is likely a factor, at least one study has
found that the barrier in such visits is more likely to
be provider-based than parental [18]. Also, reimbursement
levels may not be suﬃcient to encourage providers to
expand immunizations outside of well-child visits [19].
Finally parents who bring their children in for sick visits or
other encounters without immunizations may easily believe
that their child has received all needed care, including
immunizations. Most parents of children who are not UTD
believetheirchildhasreceivedallneededimmunizationsand
may not understand the diﬀerence between well-child and
other types of encounters [20]. Solutions to this problem
may lie in the redesign of early childhood care encounters
within clinics and healthcare providers that are concerned
about their immunization rates, to deemphasize urgent care
or access to short, single-purpose visits in favor of longer
appointments during which aspects of routine care such as
immunizations are also reviewed.
A strength of the present study is the combination of
administrative data on all encounters with immunization
records reported separately to the ALERT IIS. This approach
could potentially serve as a standard for the evaluation
of immunizations given to health plan participants and
public populations in areas that have strong immunization
information systems such as ALERT. A similar approach by
Dombkowski et al. [21] has previously demonstrated the
utility of combining registry and Medicaid data in Michigan
for assessing missed opportunities to vaccinate asthmatics
against inﬂuenza. The potential for missed opportunities to
be misclassiﬁed as missed visits when conducting milestone
analysis solely from immunization record data without all
encounters should lead to caution in interpreting the balance
of responsibility between parents and providers for children
notbeingup-to-date.Alsothepresentstudydoesnotaddress
the extent to which parental reluctance to accept all age-
appropriateimmunizations maylimittheabilityofprovider-
based interventions to improve milestone immunization
completeness.
From the perspective of a state immunization program
with concerns for improving immunization rates, the devel-
opment of a roadmap showing where and how children are
falling behind is invaluable for setting policy. While national
measurements such as the NIS can identify variations in
rates between states, state-level programs have been left
on their own to identify what in-state factors are aﬀecting
their rates [6]. Also because immunization levels are often
taken as a measure for overall quality of care in early
childhood [1], counting doses by age two is not as strong a
proxy as is the checking of timely receipt of age-appropriate
immunizations across the entire period from birth to age
two. A risk of solely depending on immunization results at
age two is that UTD and non-UTD status may be taken as
discrete categories, irrespective of age-appropriate history.
Searching for explanatory factors for these two categories
maybemisleadingfordevelopinganunderstandingofwhere
barriers exist and where interventions are needed. This is
illustrated in the present study by the observation that only
a minority of children were consistently on schedule at all
milestone ages, and that the majority fell behind at one or
more point in receiving immunizations. Falling behind by
milestone period is a more useful concept for intervention
than ﬁnal UTD status. A useful model then is that most
children are at great risk of falling behind at many points,
and that their ﬁnal status reﬂects the work that providers do
to catch them up to standard.
The concept of milestone ages and the charting of
children’s progress through the milestones, as advanced by
Luman and Chu [11], provides such a roadmap for use by
local programs. Local variations in patterns of falling behind
and catching up, however, argue for analyzing milestones
with available local or state-level data to determine where
problems are most salient. Yet, while speciﬁc ﬁndings may
diﬀer, the present study conﬁrms the utility of the milestone
approach for a local population.
The present study is representative only of a single state
population, and of children enrolled through the Oregon
Health Plan. Because children in the OHP are generally
enrolled in the same health plans, with the same networks
of providers and beneﬁts, as privately insured children, their
encounters are potentially similar to the wider state popula-
tion.Overallin2007,theOIPestimatedthatamongallOHP-
enrolled 2-year-olds, the UTD rate for a 4:3:1:3:3:1 series
was75.2%,ascomparedto72.9%amongnon-OHP-enrolled
children. However, the present study population also reﬂects
a group with stable, long-term enrollment in OHP. Children
with short-term enrollment or who disenrolled after age
1 are not represented and may have substantially diﬀerent
patterns of falling behind and catching up to recommended
immunizations. Also it is expected that individual health
plans under the OHP are a signiﬁcant factor in the receipt of
age-appropriate immunizations; however, this information
was not included in the present analysis dataset.
Another limitation on the present results is that the
deﬁnition of encounters was deliberately set broadly, to
reﬂect any encounters in which vaccinations could have
been delivered as opposed to well-child visits, during which
immunization screening should be routine. As such, theJournal of Biomedicine and Biotechnology 9
possibility of raising immunization rates by converting all
missed opportunities here should be taken as an upper ﬁgure
to what is possible. Institutional, scheduling, reimbursement
and parental acceptance are all potential factors on what
proportion of encounters without vaccinations could incor-
porate immunization screening.
Also, encounters were not stratiﬁed by type of provider
or principal reason for each encounter. While some research
suggests that provider type is not a key factor for immu-
nization performance when the volume of well-child visits
is taken account [22], no provider information was included
in the present study dataset to conﬁrm or identify other
relevant provider features. Whether encounters without
immunizations are due to children using a spectrum of
diﬀerent provider types, to parental reluctance, or are due
to use of settings such as urgent care in place of scheduled
well-child visits cannot be determined from the data of this
study.
5. Conclusion
The milestone approach to evaluating early childhood
immunizations provides a useful perspective for under-
standing the time-based progression of children through
immunization periods. However, the results of this study
warrant some caution in the use of immunization record
data only in assessing failure to have age-appropriate
immunizations because of the chance of misclassiﬁcation
of missed opportunities by providers as missed visits by
parents. Nevertheless, for local assessment by public agencies
or health plans, and for the design of interventions to
improve immunization rates, looking at the patterns by
which children fall behind or catch up on immunizations at
milestone periods is a valuable next step beyond the count of
vaccine doses received by age two.
Acknowledgments
This study was in part funded under CDC Grant no.
280540/09. The authors also wish to thank Diana Bartlett,
Laura Pabst, Jim Gaudino, Holly Groom, and Elizabeth
Luman for their work in review of this research.
References
[ 1 ]L .R o d e w a l d ,E .M a e s ,J .S t e v e n s o n ,B .L y o n s ,S .S t o k l e y ,a n d
P. Szilagyi, “Immunization performance measurement in a
changingimmunizationenvironment,”Pediatrics,vol.103,no.
4, part 2, pp. 889–897, 1999.
[2] National Committee for Quality Assurance (NCQA),
HEDIS 2009: Healthcare Eﬀectiveness Data & Information
Set. Vol. 1: Narrative, vol. 1, National Committee for Quality
Assurance (NCQA), Washington, DC, USA, 2008.
[ 3 ]P .J .S m i t h ,D .C .H o a g l i n ,M .P .B a t t a g l i a ,M .K h a r e ,
and L. E. Barker, “Statistical methodology of the National
Immunization Survey, 1994–2002,” Vital and Health Statistics.
Series 2, Data Evaluation and Methods Research, no. 138, pp.
1–55, 2005.
[4] J. H. Glauber, “The immunization delivery eﬀectiveness
assessment score: a better immunization measure?” Pediatrics,
vol. 112, no. 1, part 1, pp. e39–e45, 2003.
[5] Centers for Disease Control and Prevention, “Recommended
immunization schedules for persons 0–18 years—United
States, 2007,” Morbidity and Mortality Weekly Report, vol. 55,
no. 51, pp. Q1–Q4, 2007.
[6] A. Shefer, J. Santoli, and J. A. Singleton, “Measuring vaccina-
tion coverage—where are we now and where are we going?”
Journal of Public Health Management and Practice, vol. 13, no.
6, pp. 541–543, 2007.
[ 7 ]K .J .D o m b k o w s k i ,P .M .L a n t z ,a n dG .L .F r e e d ,“ T h en e e d
for surveillance of delay in age-appropriate immunization,”
American Journal of Preventive Medicine, vol. 23, no. 1, pp. 36–
42, 2002.
[8] K. J. Dombkowski, P. M. Lantz, and G. L. Freed, “Risk
factorsfordelayinage-appropriatevaccination,”Public Health
Reports, vol. 119, no. 2, pp. 144–155, 2004.
[9] G. H. Dayan, K. M. Shaw, A. L. Baughman, et al., “Assessment
of delay in age-appropriate vaccination using survival analy-
sis,”AmericanJournalofEpidemiology,vol.163,no.6,pp.561–
570, 2006.
[10] E. T. Luman, L. E. Barker, M. M. McCauley, and C. Drews-
Botsch, “Timeliness of childhood immunizations: a state-
speciﬁc analysis,” American Journal of Public Health, vol. 95,
no. 8, pp. 1367–1374, 2005.
[11] E. T. Luman and S. Y. Chu, “When and why children fall
behind with vaccinations. Missed visits and missed oppor-
tunities at milestone ages,” American Journal of Preventive
Medicine, vol. 36, no. 2, pp. 105–111, 2009.
[ 1 2 ]L .E .R o d e w a l d ,P .G .S z i l a g y i ,S .G .H u m i s t o n ,R .B a r t h ,
R. Kraus, and R. F. Raubertas, “A randomized study of
tracking with outreach and provider prompting to improve
immunizationcoverageandprimarycare,”Pediatrics,vol.103,
no. 1, pp. 31–38, 1999.
[ 1 3 ]J .M .S a n t o l i ,P .G .S z i l a g y i ,a n dL .E .R o d e w a l d ,“ B a r r i e r s
to immunization and missed opportunities,” Pediatric Annals,
vol. 27, no. 6, pp. 366–374, 1998.
[14] C. S. Minkovitz, A. D. Belote, S. M. Higman, J. R. Serwint, and
J. P. Weiner, “Eﬀectiveness of a practice-based intervention to
increase vaccination rates and reduce missed opportunities,”
Archives of Pediatrics and Adolescent Medicine, vol. 155, no. 3,
pp. 382–386, 2001.
[15] P. G. Szilagyi, L. E. Rodewald, S. G. Humiston, et al.,
“Reducing missed opportunities for immunizations: easier
saidthandone,”ArchivesofPediatricsandAdolescentMedicine,
vol. 150, no. 11, pp. 1193–1200, 1996.
[16] S. S. Sabnis, A. J. Pomeranz, P. S. Lye, and M. M. Amateau,
“Do missed opportunities stay missed? A 6-month follow-
up of missed vaccine opportunities in inner city Milwaukee
children,” Pediatrics, vol. 101, no. 5, p. e5, 1998.
[17] M.F.Daley,B.L.Beaty,J.Barrow,etal.,“Missedopportunities
for inﬂuenza vaccination in children with chronic medical
conditions,”ArchivesofPediatricsandAdolescentMedicine,vol.
159, no. 10, pp. 986–991, 2005.
[18] S. L. Udovic, T. A. Lieu, S. B. Black, P. M. Ray, G. T.
Ray, and H. R. Shineﬁeld, “Parent reports on willingness to
accept childhood immunizations during urgent care visits,”
Pediatrics, vol. 102, no. 4, p. e47, 1998.
[ 1 9 ]T .K .M c I n e r n y ,W .L .C u l l ,a n dB .K .Y u d k o w s k y ,“ P h y s i c i a n
reimbursement levels and adherence to american academy
of pediatrics well-visit and immunization recommendations,”
Pediatrics, vol. 115, no. 4, pp. 833–838, 2005.10 Journal of Biomedicine and Biotechnology
[20] E. T. Luman, S. Stokley, D. Daniels, and R. M. Klevens,
“Vaccination visits in early childhood: just one more visit to
be fully vaccinated,” American Journal of Preventive Medicine,
vol. 20, no. 4, supplement 1, pp. 32–40, 2001.
[ 2 1 ]K .J .D o m b k o w s k i ,M .M .D a v i s ,L .M .C o h n ,a n dS .J .C l a r k ,
“Eﬀect of missed opportunities on inﬂuenza vaccination rates
among children with asthma,” Archives of Pediatrics and
Adolescent Medicine, vol. 160, no. 9, pp. 966–971, 2006.
[ 2 2 ]A .G u t t m a n n ,D .M a n u e l ,P .T .D i c k ,T .T o ,K .L a m ,a n dT .
A. Stukel, “Volume matters: physician practice characteristics
and immunization coverage among young children insured
through a universal health plan,” Pediatrics, vol. 117, no. 3, pp.
595–602, 2006.